Cellnovo recieves CE mark for Type 1 Diabetes management system

Cellnovo has received CE Mark approval for its Cellnovo mobile diabetes management system, aimed at patients with Type 1 Diabetes. Cellnovo's system uses mobile, wireless technology, and includes an insulin patch pump, a wireless, touch screen handset with a built-in blood glucose monitor, and an extendable applications software system. According to the comany, the system's rechargeable patch pump is the smallest and most accurate on the market and the touch-screen, wireless handset will be easy to use for anyone familiar with smartphone technology. The system can gather and transmit data on glucose levels directly to physicians, so patients do not need to keep detailed records.